Head of Investor Relations
Ocular Therapeutix, Inc (OCUL)Equibles does not estimate personal net worth.
Get an email with a short summary when Ocular Therapeutix, Inc publishes a filing, an earnings call transcript or a press release.
Get OCUL alertsWilliam S. Slattery is recorded as Head of Investor Relations at Ocular Therapeutix, Inc (OCUL). William S. Slattery has spoken on 2 earnings calls across 1 company, most recently for Ocular Therapeutix, Inc on May 5, 2026. Ocular Therapeutix, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ocular Therapeutix, Inc includes Pravin Dugel (CEO), Pravin U. Dugel (CEO, Chairman and Board Member), Pravin U. Dugel, M.D. (CEO and Chairman) and 7 others.
“Earlier this morning, we issued a press release and filed our quarterly report on Form 10-Q, outlining our financial results and business updates for the first quarter of 2026.”
“Earlier this morning, we issued a press release and filed our quarterly report on Form 10-Q, outlining our financial results and business updates for the third quarter of 2025, along with several updates to our registrational programs for AXPAXLI, also referred to as OTX-TKI in wet AMD and non-proliferative diabetic…”
Biotechnology · Healthcare
Head of Investor Relations
